Monday, October 24, 2016
While The New York Times's editorial board maintains its current silence on marijuana policy reform, its reporters continue give its readers necessary information and perspectives on the marijuana reform movement from across the country. In today's Times, Thomas Fuller reports on the legalization debate in California. The article begins:
To the red-and-blue map of American politics, it may be time to add green. The movement to legalize marijuana, the country’s most popular illicit drug, will take a giant leap on Election Day if California and four other states vote to allow recreational cannabis, as polls suggest they may.
The map of where pot is legal could include the entire West Coast of the United States and a string of states reaching from the Pacific Ocean to Colorado, raising a stronger challenge to the federal government’s ban on the drug.
In addition to California, Massachusetts and Maine both have legalization initiatives on the ballot next month that seem likely to pass. Arizona and Nevada are also voting on recreational marijuana, with polls showing Nevada voters evenly split.
The passage of recreational marijuana laws in Alaska, Colorado, Oregon and Washington over the last four years partly unlocked the door toward eventual federal legalization. But a yes vote in California, which has an economy the size of a large industrial country’s, could blow the door open, experts say.
“If we’re successful, it’s the beginning of the end of the war on marijuana,” said Gavin Newsom, the lieutenant governor of California and a former mayor of San Francisco. “If California moves, it will put more pressure on Mexico and Latin America writ large to reignite a debate on legalization there.”
The market for both recreational and medicinal marijuana is projected to grow to $22 billion in four years from $7 billion this year if California says yes, according to projections by the Arcview Group, a company that links investors with cannabis companies.
“This is the vote heard round the world,” said Arcview’s chief executive, Troy Dayton. “What we’ve seen before has been tiny compared to what we are going to see in California.”
And yet scholars who have studied these legalization measures say that to a large extent they are very much a shot in the dark, a vast public health experiment that could involve states that hold 23 percent of the United States population — and generate a quarter of the country’s economic output — carried out with relatively little scientific research on the risks. In addition, there are 25 states that already permit medical marijuana.